Product NDC: | 17478-704 |
Proprietary Name: | Paremyd |
Non Proprietary Name: | Hydroxyamphetamine hydrobromide, tropicamide |
Active Ingredient(s): | 10; 2.5 mg/mL; mg/mL & nbsp; Hydroxyamphetamine hydrobromide, tropicamide |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 17478-704 |
Labeler Name: | Akorn, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019261 |
Marketing Category: | NDA |
Start Marketing Date: | 19920130 |
Package NDC: | 17478-704-12 |
Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (17478-704-12) > 15 mL in 1 BOTTLE, DROPPER |
NDC Code | 17478-704-12 |
Proprietary Name | Paremyd |
Package Description | 1 BOTTLE, DROPPER in 1 CARTON (17478-704-12) > 15 mL in 1 BOTTLE, DROPPER |
Product NDC | 17478-704 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Hydroxyamphetamine hydrobromide, tropicamide |
Dosage Form Name | SOLUTION |
Route Name | OPHTHALMIC |
Start Marketing Date | 19920130 |
Marketing Category Name | NDA |
Labeler Name | Akorn, Inc. |
Substance Name | HYDROXYAMPHETAMINE HYDROBROMIDE; TROPICAMIDE |
Strength Number | 10; 2.5 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes | Adrenergic Agonists [MoA],Adrenergic Receptor Agonist [EPC],Anticholinergic [EPC],Cholinergic Antagonists [MoA] |